Evaluation of the vasoconstrictive effects of topical steroids by laser- Doppler-perfusion-imaging

Acta Dermato-Venereologica

Volumn 78, Issue 1, 1998, Pages 15-18

  Sommer, Anja ^a,b   Veraart, Joep ^a   Neumann, Martino ^a   Kessels, Alfons ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blanching; Bloodflow; Corticosteroids; Coscosteroid potency; McKenzie study

Indexed keywords

CLOBETASOL PROPIONATE;

ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG POTENCY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; FEMALE; GLUCOCORTICOIDS; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; REFERENCE VALUES; SKIN; VASOCONSTRICTION;

EID: 0031939334     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015559850135751     Document Type: Article

References (31)

1. Baxter JD. Glucocorticoid hormone action. Pharm Therap Bulletin 1976; 2: 605-609.
2. Ponec M, Kempenaar JA, De Kloet ER. Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy. J Invest Dermatol 1981; 76: 211-214.
3. Kragballe K. Topical corticosteroids: mechanisms of action. Acta Derm Venereol (Stockh) 1989; 69 (Suppl. 151): 7-10.
4. McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol 1962; 86: 608-610.
5. Clarys P, Wets L, Barel A, Gabard B. The skin blanching assay with halcinonide, influence of halcinonide concentration and application time. J Eur Acad Derm Venero 1995; 5: 250-257.
6. Queille-Roussel C, Poncet M, Schaefer H. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. Br J Dermatol 1991; 124: 264-270.
7. Zaun H, Altmeyer P, Ergebnisse reflexionsphotometrischer Bestimmungen der Vasokonstriktion nach topischer Steroid-applikation Methode, Aussagekraft, Fehlerquellen. Arch Derm Forsch 1973; 247: 379-386.
8. Altmeyer P, Zaun H. Ergebnisse reflexionsphotometrischer Bestimmungen der Vasokonstriktion nach topischer Steroid-applikation. V Arch Dermatol Res 1976; 255: 51-56.
9. Feather JW, Ryatt KS, Dawson JB, Cotterill JA, Barker DJ, Ellis DJ. Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations. Br J Dermatol 1982; 106: 437-444.
10. Andersen P, Milioni K, Maibach H. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study. Br J Dermatol 1993; 128: 660-665.
11. Blazek V, Wienert V. Ein neues Verfahren zur Objektivierung des Vasokonstriktionstests nach topischer Anwendung von Kortikosteroiden. Akt Dermatol 1980; 6: 129-134.
12. Pershing LK, Corlett JL, Lambert LD, Poncelet CE. Circadian activity of topical 0.05% betamethasone dipropionate in human skin in vivo. J Invest Dermatol 1994; 102: 734-739.
13. Aiche JM, Lafaze CL, Bouzat J. Evaluation de la disponibilite topique des corticoides par thermographie. J Pharm Belg 1980; 35: 187-95.
14. Kristensen JK, Wadskov S, Henriksen O. Dose-dependent effect of topical corticisteroids on bloodflow in human cutaneous tissue. Acta Derm Venereol (Stockh) 1978; 58: 145-148.
15. Petersen LJ, Kristensen JK. Time-course of corticosteroid-induced blood flow in normal cutaneous tissue - quantitative measurements during 72 h of treatment. Clin Exp Dermatol 1989; 14: 210-213.
16. Bisgaard H, Kristensen JK, Sondergaard J. A new technique for ranking vasculature corticosteroid effects in humans using laser-Doppler velocimetry. J Invest Dermatol 1986; 86: 275-278.
17. Falconi G, Rossi GL. Paper-patch test for evaluating vasoconstrictive activity of corticosteroids. Arch Dermatol 1972; 105: 856-858.
18. Smith EW. Four decades of topical corticosteroid assesment. Curr Probl Dermatol 1995; 22: 124-131.
19. Kirsch J, Gibson JR, Darley CR. Forearm site variation with the corticosteroid vasoconstrictor assay. Br J Dermatol 1982; 106: 495.
20. Engel DJS, Marx AF, Rekker RF, v Wijk L. Topically active corticosteroids. Arch Dermatol 1974; 109: 863-865.
21. Uhl E, Sirsjo A, Haapaniemi T, Nilsson G, Nylander G. Hyperbaric oxygen improves wound healing in normal and ischemic skin tissue. Plast Reconstr Surg 1994; 93 (4): 835-841.
22. Troilius A, Wardell K, Bornmyr S, Nilsson GE, Ljunggren B. Evaluation of port wine stain perfusion by laser Doppler imaging and thermography before and after argon laser treatment. Acta Derm Venereol (Stockh) 1992; 72: 6-10.
23. Haigh JM, Kaufer I. Assessment of topical corticosteroid preparations: the human skin blanching assay. Int J Pharm 1984; 19: 245-262.
24. Burdock KH. Various vagaries of vasoconstriction. Arch Dermatol 1974; 110: 238.
25. Nilsson GE, Wardell K. Laser doppler- perfusion monitoring and imaging of blood microcirculation. SPIE 1994; 2136: 54-62.
26. Wardell K, Nilsson G. Laser Doppler imaging of the skin. In: Serup J, Jemec GBE, eds. Non-invasive methods and the skin, 1995, p. 421-428.
27. Harding SM, Sohail S, Busse MJ. Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations. Clin Exp Dermatol 1985; 10: 13-21.
28. Ruetten W, ed. Untersuchung zu Laser-Doppler-Verfahren in stark streuenden Medien mit Hilfe der Monte-Carlo-Methode. Verlag Shaker, D 82, promot. RWTH Aachen, 1994: 5.
29. Noon JP, Evans CE, Haynes WG, Webb DJ, Walker BR. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids. Br J Dermatol 1996; 134: 837-842.
30. McKenzie AW. Percutaneous absorption of steroids. Arch Dermatol 1962; 86: 91-94.
31. Meyer E, Smith EW, Haigh JM. Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching. Br J Dermatol 1992; 127: 379-381.